Rosso R

No ORCID on file · 3 papers in corpus
2025
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm.
The oncologist ·doi:10.1093/oncolo/oyae325

Ovarian clear cell carcinoma (OCCC) accounts for ~10% of all epithelial ovarian cancers and is considered a different entity from the more common high-grade serous ovarian carcinoma (HGSC), with distinct clinical presentations, different ri…

2025
Spinal Analgesia Versus Intravenous Low-Dose Oxycodone for Pain Management After Robotic Hysterectomy: Preliminary Results from an ERAS Institution.
Journal of clinical medicine ·doi:10.3390/jcm14196957

Background: Robotic hysterectomy and Enhanced Recovery After Surgery (ERAS) are two significant improvements in gynecologic surgery, both associated with decreased postoperative pain and faster recovery. Spinal analgesia guarantees excellen…

other 1985
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer
Gynecologic Oncology ·doi:10.1016/0090-8258(85)90210-0

A combination chemotherapy including cisplatin, 25 mg/m2 on Days 1,8; methotrexate, 30 mg/m2 on Day 1; and 5-fluorouracil, 600 mg/m2 on Day 1 has been evaluated in 28 previously untreated and 10 pretreated patients with advanced ovarian can…